Episode 90: Complexities of Designing Clinical Trials

3 Podcast Guests Headshots for Episode: Complexities of Designing Clinical Trials

Episode 90: Complexities of Designing Clinical Trials

On this special episode, Chadi hosts three phenomenal physicians to help us better understand the complexity of designing and executing clinical trials. Hira Mian, MD, faculty of health sciences, McMaster University (Canada), and Murali Janakiram, MD, MS, assistant professor, City of Hope, both faced and continue to face challenges in bringing their clinical trial ideas to light. Saad Usmani, MD, MBA, FACP, chief of myeloma service, Memorial Sloan Kettering Cancer Center, joins as a senior investigator to shed light on the journey and to advise both junior faculty on what can be done next. The group reacts to trial ideas they’ve each had and continue to funding roadblocks. They consider how long down the road researchers should look when formulating a clinical trial design, how limited funding availability figures to be a lasting barrier for many important study ideas, how junior faculty members are vying for such funding to get published research under their belt and earn promotions, and so many more intricacies involved in the clinical trial landscape. This is a perfect episode for anyone interested in clinical trials and wanting to understand the role of a clinician investigator.

Related Resources

N/A

Subscribe to Healthcare Unfiltered

Other Episodes You May Enjoy...

Episode 209: Lymphoma: A Year in Review

Leading into the ASH Annual Meeting, Dr. Kami Maddocks, professor in the Division of Hematology at The Ohio State University and medical director of infusion services at The James Comprehensive Cancer Center, provides an in-depth analysis of advancements in non-Hodgkin lymphoma care, with a focus on aggressive B-cell lymphoma. She explores the evolving roles of

Read More

Episode 208: Vivek’s Takes: ESMO 2024 and AACR Debate

Dr. Vivek Subbiah returns for another edition of Vivek’s Takes, sharing his insights on key updates from ESMO Congress 2024, including breakthroughs in neuroendocrine tumors, gastric cancer, and non-small cell lung cancer. He also delves into the highlights of his AACR debate on integrating early cancer detection with AI, arguing for the transformative potential of

Read More

Episode 207: Advances in Bladder Cancer With Andrea Apolo

Chadi welcomes Dr. Andrea Apolo, an internationally recognized leader in bladder cancer research from the National Cancer Institute. Dr. Apolo shares her expertise on recent advancements in urothelial cancer therapy, including key breakthroughs in checkpoint inhibition that have marked a significant turning point in treatment. The conversation delves into optimal sequencing and combination strategies for

Read More